Latest news with #Gorog
Yahoo
10-06-2025
- Automotive
- Yahoo
Aussies at 'risk' as dangerous road problem reaches record-breaking levels: 'Rapid growth'
Aussie road users are growing increasingly fed up with the deteriorating state of the tarmac across the country. New data reveals reports of sub-par roads and bike paths have tripled in the past three years, with "no signs of slowing down". While the number of reports correlates with an uptick in Aussies opting to travel on their bikes, the state of roads poses an "increasing risk" to the wellbeing of cyclists, according to Danny Gorog, CEO of council reporting app Snap Send Solve. Cycling advocacy group Bicycle NSW's CEO Peter McLean has called on authorities to pay attention to the complaints, telling Yahoo it's critically important "all three tiers" of government acknowledge that there are more cyclists than ever on the roads. "We need to evolve and react to managing our assets and infrastructure more appropriately," he said. "People want better, more consistent infrastructure, and where they're not seeing it, they are reporting it," he said. Since 2020, cycling has seen a "massive uptake", according to McLean. Now, over five million Australians are riding a bike every week, particularly with the advent of e-bikes. With that, has come a rise in complaints on the state of infrastructure meant to serve cyclists. Last year, there was a "record-breaking" 5,235 reports of issues in bike paths including crumbling tarmac, regular debris in the way, as well as overgrown nature strips across the country, according to Snap Send Solve data. 2025 looks like it's going to be even worse with 3,153 reports already recorded between January and May this year. "This rapid growth strongly suggests that conditions on the ground are deteriorating year over year," Gorog told Yahoo News Australia. While the Snap Send Solve app itself is increasing in popularity among responsible citizens, he believes the rise in complaints is "unlikely" to be explained simply by reporting behaviour alone. "It signals worsening infrastructure conditions, poor repairs, ageing bike lanes, and potentially inadequate maintenance cycles," he said. He warns the current pace of deterioration could "undermine broader mobility goals and pose increasing risks to cyclists." Gorog hopes the insights will guide smarter investments and ongoing upgrades from authorities. 🚨 Drivers warned major road rule change with $961 fines 'just weeks' away 📸 Cyclist's heated exchange with driver over 'deliberate' roadside act 👮 'Unbelievable' moment cyclist swerves in front of driver draws police response It's not just the quality of the roads putting cyclists at risk, but also fellow road users like car drivers. A disproportionate amount of crashes involve cyclists on Australian roads despite them being a small percentage of overall road users. Last year, cyclist deaths jumped from 34 in 2023 to 38 in 2024, an 11.8% increase, with motor vehicles involved in the majority of crashes. Footage shared earlier this year shows a scary near-miss between a driver and a cyclist in the Melbourne suburb of Brunswick. Cyclist Rory Meister told Yahoo News he thought it was "absurd" the driver didn't see him despite having flashing lights on his bike. He said incidents with drivers are alarmingly frequent. McLean previously told Yahoo education and awareness are the first port of call for improving safety for cyclists. "Fundamentally, we need better awareness at an early stage of when people are getting their licenses," he said. "There's lots of great drivers out there and we just need to equalise everyone on the road." Do you have a story tip? Email: newsroomau@ You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Medscape
05-06-2025
- Health
- Medscape
Diabetes Status May Not Affect Outcomes of Preventive PCI
The PREVENT trial found preventive percutaneous coronary intervention (PCI) combined with optimal medical therapy was more effective than medical therapy alone in reducing major adverse cardiac events in patients with non–flow-limiting vulnerable plaques. The new analysis found patients with non–flow-limiting vulnerable plaques had similar 2-year cardiac outcomes regardless of diabetes status, but those who received preventive PCI combined with optimal medical therapy had lower rates of cardiac events than those who received medical therapy alone. METHODOLOGY: The post hoc analysis of the PREVENT data compared the clinical outcomes of preventive PCI plus optimal medical therapy and medical therapy alone in patients with (n = 490) or without (n = 1116) diabetes. Plaques were defined as non–flow-limiting when the fractional flow reserve was > 0.80; vulnerable plaques were identified using intracoronary imaging. The primary endpoint was a composite of cardiac death, target vessel myocardial infarction, ischemia-driven target vessel revascularization, or hospitalization for unstable or progressive angina at 2 years after randomization; the median follow-up duration was 4.3 years. TAKEAWAY: At 2 years, the incidence of the composite primary endpoint was not significantly different between patients with diabetes and those without the condition (1.8% and 1.9%, respectively; P = .956). = .956). The composite primary endpoint occurred less frequently with preventive PCI than with optimal medical therapy alone for both patients with diabetes (0% vs 3.7%; log-rank P = .003) and those without diabetes (0.5% vs 3.2%; log-rank P < .001). = .003) and those without diabetes (0.5% vs 3.2%; log-rank < .001). The reduced incidence of the primary endpoint with preventive PCI was mainly driven by reduced rates of ischemia-driven target vessel revascularization and hospitalizations for unstable or progressive angina in both patients with diabetes and those without the disorder. IN PRACTICE: 'These findings support that preventive PCI…irrespective of diabetes status, in patients with non–flow-limiting vulnerable coronary plaques,' the researchers wrote. Vulnerable plaques 'may be guilty by association but may not be the sole culprit behind residual cardiovascular risk,' wrote Diana A. Gorog, MD, PhD, of Imperial College London, London, England, in an editorial accompanying the journal article. Such plaques 'may be just one marker of a vulnerable patient, but not the only determinant of risk. Perhaps we need to find better ways of identifying the vulnerable patient, rather than focusing solely on vulnerable plaques,' Gorog added. SOURCE: This study was led by Min Chul Kim of Chonnam National University Hospital in Gwangju, South Korea. It was originally presented at American College of Cardiology (ACC) Scientific Session 2024 and was published online on May 29, 2025, in European Heart Journal . LIMITATIONS: The clinical outcomes were exploratory as the study was powered only for the composite primary endpoint, with event rates lower than anticipated. The researchers did not differentiate between type 1 and type 2 diabetes, which might have limited the generalizability of the findings. Intravascular imaging at follow-up was not performed routinely. DISCLOSURES: This study was funded by the CardioVascular Research Foundation, Abbott, Yuhan Corp, CAH-Cordis, Philips, and Infraredx. Several authors reported receiving research grants, consulting fees, and honoraria from various pharmaceutical and healthcare companies, including the funding agencies.
